Persistent Asset Partners »

Black Diamond Therapeutics I shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Black Diamond Therapeutics I shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Black Diamond Therapeutics I

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics I held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics I by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $13k 512 25.67

More positions owned by Persistent Asset Partners

Centene Corporation (CNC)
Molina Healthcare (MOH)
Anthem (ELV)
Intel Corporation (INTC)
Axt (AXTI)
Terns Pharmaceuticals (TERN)
Sandisk Corp (SNDK)
Abivax Sa Sponsored Ads (ABVX)
Johnson & Johnson (JNJ)
Brightspring Health Svcs (BTSG)
Viking Therapeutics Call Call Option
Viking Therapeutics (VKTX)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Nebius Group Shs Class A (NBIS)

View all positions for Persistent Asset Partners

Top funds holding Black Diamond Therapeutics I

Group One Trading
Persistent Asset Partners

View all funds holding Black Diamond Therapeutics I